Scale-Up DoE Strategies for Robust Pharma Processes

Identifying symptoms that signal potential issues during scale-up is the first critical step in maintaining process robustness. Symptoms may manifest as variances in product quality attributes, process parameters, or operational…

Using CPV to Confirm Process Robustness After Scale-Up

Identifying symptoms directly from the manufacturing floor or laboratory is essential for timely intervention. Key performance indicators (KPIs), operational metrics, and quality failures are all potential signals indicating that the…

Using CPV to Confirm Process Robustness After Scale-Up

Symptoms indicating potential issues with process robustness often arise early in production following scale-up. Recognizing these signals is crucial for timely intervention. Common signals include:Click to read the full article.